Evaluation of anti oxidative effect of linagliptin on type 2 diabetic patients.
Not Applicable
- Conditions
- type2 diabetes
- Registration Number
- JPRN-UMIN000015308
- Lead Sponsor
- linagliptin study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who started renin angiotensin system inhibitor, statin, and/or pioglitazon within 1 month
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of MDA-LDL colesterol and urinary 8OHdG
- Secondary Outcome Measures
Name Time Method Change of high sensitive CRP and urinary LFABP